List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 28 studies with search of: "SuperGen" [Exact]
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Safety of SGI-1776, A PIM Kinase Inhibitor to Treat Docetaxel Refractory Prostate Cancer and Relapsed/Refractory Non Hodgkins Lymphoma (NHL)
Conditions: Prostate Cancer;   Non-Hodgkins Lymphoma
Intervention: Drug: SGI-1776
2 Completed Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Blast Phase Who Are Refractory to Imatinib Mesylate (Gleevec)
Condition: Chronic Myelogenous Leukemia
Intervention: Drug: decitabine (5-aza-2'deoxycytidine)
3 Recruiting MP470 in Treating Patients With Unresectable or Metastatic Solid Tumor or Lymphoma
Conditions: Lymphoma;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: multitargeted receptor tyrosine kinase inhibitor MP470;   Other: laboratory biomarker analysis;   Other: pharmacological study;   Procedure: positron emission tomography
4 Recruiting Study of Rubitecan in Cancer Patients With Renal or Hepatic Dysfunction
Condition: Tumors
Intervention: Drug: Rubitecan
5 Completed Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Chronic Phase Who Are Refractory to Imatinib Mesylate (Gleevec)
Condition: Chronic Myelogenous Leukemia
Intervention: Drug: decitabine (5-aza-2'deoxycytidine)
6 Recruiting Orathecin + Gemcitabine Versus Placebo + Gemcitabine in Chemonaive Non-Resectable Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Drug: Rubitecan
7 Recruiting Safety of MP470 in Combination With Standard-of-Care Chemotherapy Regimens to Treat Solid Tumors
Condition: Malignant Disease
Interventions: Drug: MP-470 + topotecan;   Drug: MP-470 + docetaxel;   Drug: MP-470 + erlotinib;   Drug: MP-470 + paclitaxel/carboplatin;   Drug: MP-470 + carboplatin/etoposide
8 Active, not recruiting Nitrocamptothecin Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: gemcitabine hydrochloride;   Drug: rubitecan
9 Active, not recruiting Nitrocamptothecin Compared With Other Chemotherapy in Treating Patients With Recurrent or Refractory Cancer of the Pancreas
Condition: Pancreatic Cancer
Interventions: Drug: fluorouracil;   Drug: gemcitabine hydrochloride;   Drug: mitomycin C;   Drug: rubitecan
10 Active, not recruiting Nitrocamptothecin or Fluorouracil in Treating Patients With Recurrent or Refractory Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: fluorouracil;   Drug: rubitecan
11 Completed Nitrocamptothecin in Treating Patients With Recurrent Non-Small Cell Lung Cancer
Condition: Lung Cancer
Intervention: Drug: rubitecan
12 Completed Nitrocamptothecin in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Condition: Breast Cancer
Intervention: Drug: rubitecan
13 Terminated Dose-Finding Study Using Pentostatin for Injection in the Treatment of Steroid-Refractory aGvHD
Condition: Acute Graft Versus Host Disease
Intervention: Drug: pentostatin for injection
14 Completed Nitrocamptothecin in Treating Patients With Soft Tissue Sarcomas
Conditions: Gastrointestinal Stromal Tumor;   Sarcoma;   Small Intestine Cancer
Intervention: Drug: rubitecan
15 Completed Nitrocamptothecin in Treating Patients With Metastatic Melanoma
Condition: Melanoma (Skin)
Intervention: Drug: rubitecan
16 Recruiting MP470 and Chemotherapy in Treating Patients With Cancer
Condition: Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: carboplatin;   Drug: docetaxel;   Drug: erlotinib hydrochloride;   Drug: etoposide;   Drug: multitargeted receptor tyrosine kinase inhibitor MP470;   Drug: paclitaxel;   Drug: topotecan hydrochloride
17 Active, not recruiting Nitrocamptothecin in Treating Patients With Locally Advanced or Metastatic Stomach Cancer That Cannot Be Removed During Surgery
Conditions: Esophageal Cancer;   Gastric Cancer
Intervention: Drug: rubitecan
18 Active, not recruiting Nitrocamptothecin in Treating Patients With Advanced or Recurrent Colorectal Cancer
Condition: Colorectal Cancer
Intervention: Drug: rubitecan
19 Completed Decitabine Versus Supportive Care in Adults With Advanced-Stage MDS
Condition: Myelodysplastic Syndrome
Intervention: Drug: decitabine (5-aza-2'deoxycytidine)
20 Completed Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Accelerated Phase Who Are Refractory to Imatinib Mesylate (Gleevec)
Condition: Chronic Myelogenous Leukemia
Intervention: Drug: decitabine (5-aza-2'deoxycytidine)

Previous Page Studies Shown (1-20) Next Page (21-28)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services